Invesaro

Stocks CAI Earnings

Earnings

Caris Life Sciences, Inc. (CAI) earnings

Quarterly results of Caris Life Sciences, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when CAI files with the SEC.

Next earnings date

Caris Life Sciences, Inc. is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Caris Life Sciences, Inc. reported revenue of $275.4M (+171% on the same quarter a year earlier) and net income of $15.3M.

Diluted earnings per share were $0.05.

Filed with the SEC on November 4, 2026.

Revenue by quarter
Q3 25: $101.6M $101.6M Q3 25Q1 25: $120.9M $120.9M Q1 25Q2 25: $181.4M $181.4M Q2 25Q3 25: $216.8M $216.8M Q3 25Q4 25: $292.9M $292.9M Q4 25Q1 26: $216.2M $216.2M Q1 26Q2 26: $263.7M $263.7M Q2 26Q3 26: $275.4M $275.4M Q3 26
Net income by quarter
Q3 25: -$67.7M -$67.7M Q3 25Q1 25: -$102.6M -$102.6M Q1 25Q2 25: -$71.8M -$71.8M Q2 25Q3 25: $24.3M $24.3M Q3 25Q4 25: $82M $82M Q4 25Q1 26: -$510K -$510K Q1 26Q2 26: -$637K -$637K Q2 26Q3 26: $15.3M $15.3M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$275.4M+171%$15.3M$0.05
Q2 FY2026June 30, 2026$263.7M+45.4%-$637K$0.00
Q1 FY2026March 31, 2026$216.2M+78.8%-$510K$0.00
Q4 FY2025December 31, 2025$292.9M-$82M-
Q3 FY2025September 30, 2025$216.8M-$24.3M$0.08
Q2 FY2025June 30, 2025$181.4M--$71.8M-$7.97
Q1 FY2025March 31, 2025$120.9M--$102.6M-$3.57
Q3 FY2025September 30, 2024$101.6M--$67.7M-$2.59

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Caris Life Sciences, Inc.'s next earnings date?

Caris Life Sciences, Inc. is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Caris Life Sciences, Inc.'s latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Caris Life Sciences, Inc. reported revenue of $275.4M and net income of $15.3M. The figures come from its filing with the SEC.

Is Caris Life Sciences, Inc.'s revenue growing?

Revenue in Q3 FY2026 was $275.4M, up 171% from $101.6M in the same quarter a year earlier.

Get an email when CAI reports

Follow CAI and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when CAI files with the SEC.

Source: quarterly figures Caris Life Sciences, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Caris Life Sciences, Inc.